Announcement PDF Company Announcement IMAGION BIOSYSTEMS LIMITED ASX: IBX 13 August 2024 Imagion Biosystems Announces Shareholder Webinar MELBOURNE – Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, is pleased to invite you to join us for a shareholder webinar where we'll explain the resolutions being proposed for the upcoming EGM and outline the next steps in the development of our MagSense® imaging technology. This is your chance to gain first-hand insights into the status of the company and our strategic direction. Webinar Highlights: • • • ExplanaOon of and reasons for the resoluOons proposed for shareholder approval Update on our business plan and key milestones Q&A session with our leadership team Date & Time: Thursday, August 15, 2024 @ 10 am AEST Registration Link: RESERVE YOUR SEAT HERE ¾ ENDS ¾ About Imagion Biosystems Imagion Biosystems is developing a new non-radioacOve and precision diagnosOc molecular imaging technology. Combining biotechnology and nanotechnology, the Company aims to detect cancer and other diseases earlier and with higher specificity than is currently possible. For more informaOon, visit h`ps://imagionbiosystems.com/investor-hub/ Authorisa=on & Addi=onal informa=on This announcement was authorised by the Board of Directors of Imagion Biosystems Limited Media & Investor Rela=ons: Email: info@imagionbio.com AU: +61 3 9692 7222